Vanguard Capital Management
ZBH icon

Vanguard Capital Management’s Zimmer Biomet ZBH Stock Holding History

Vanguard Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09B Sell
12,634,937
-158,475
-1% -$13.9M 0.02% 474
2026
Q1 		$1.16B Buy
+12,793,412
New +$1.17B 0.03% 442

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management's ZBH Position: Q2 2026 in Review

Vanguard Capital Management reduced its Zimmer Biomet (ZBH) stake by 1.2% in Q2 2026, selling an estimated $13.9M and leaving 12,634,937 shares worth $1.09B. The position accounts for 0.02% of the portfolio, ranked #474.

Vanguard Capital Management first reported a position in ZBH in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.16B in Q1 2026. 853 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Vanguard Capital Management held 12,634,937 shares of Zimmer Biomet worth $1.09B as of Q2 2026.
  • Vanguard Capital Management sold 158,475 Zimmer Biomet shares in Q2 2026, an estimated $13.9M.
  • Zimmer Biomet made up 0.02% of Vanguard Capital Management's portfolio in Q2 2026, its #474 holding.
  • Vanguard Capital Management first reported a position in Zimmer Biomet in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Zimmer Biomet position peaked at $1.16B in Q1 2026.
  • 853 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.